How signals shape DNA via gene regulation
Chromatin, the complex of DNA and proteins within the nucleus, plays a central role in gene expression and cellular function. However, studying chromatin-bound proteins has been challenging due to their intricate interactions with DNA.
To address this, researchers at Shanghai Jiao Tong University and Heidelberg University developed an advanced chromatin isolation technique that preserves protein–DNA interactions. They then applied mass spectrometry and bioinformatics analysis to examine how signaling pathways alter the chromatin-bound proteome. They published their work in Molecular & Cellular Proteomics.
The researchers found that different signaling cues, such as stress or growth factors, significantly alter chromatin composition by affecting transcription factors, chromatin remodelers and DNA repair proteins. These changes influence gene expression and cellular responses.
The findings emphasize how external signals regulate DNA-bound proteins, offering new insights into diseases driven by dysregulated signaling, such as cancer. This work opens new possibilities for developing therapies that target specific protein–DNA interactions.
This chromatin profiling technique offers a valuable tool for investigating gene regulation and has the potential to inform precision medicine strategies.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
What’s in a diagnosis?
When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.
Peer through a window to the future of science
Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.
Glow-based assay sheds light on disease-causing mutations
University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.
A game changer in cancer kinase target profiling
A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.
How scientists identified a new neuromuscular disease
NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.
Unraveling cancer’s spaghetti proteins
MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.